Delivery Order SPE2DB20D1004-SPE2DB23FG1F3
- Not listed
- This federal contract award, valued at $4,653.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,759.04 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price structure and a completion date of September 12, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,177.10 delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of March 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a specialty medication used in the management of diabetes. The contract has a ceiling value of $2,163.84 and an ultimate completion date of March 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,126.72 firm fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of March 29, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,247.84 firm fixed-price delivery order is for the pharmaceutical product Trulicity 3 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of December 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $3,526.04 firm fixed-price contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $4,469.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,081.92 for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,186.29 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of December 8, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG1F3Delivery Order
This federal contract award, valued at $1,015.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of June 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale. The contract award reviewed is not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/23/23 |